Aneri Pattani comes to Spotlight PA from The Philadelphia Inquirer, where she covered mental health, suicide and health disparities. Also, she helped launch a biweekly solutions-oriented series called Made in Philly aimed at engaging diverse communities. Previously, she uncovered New York City’s failure to protect children from lead poisoning as a reporter for WNYC, and exposed the abuses of Florida’s disability services system as a producer on the podcast Aftereffect. She has also been a James Reston reporting fellow at The New York Times, and reported from Liberia with columnist Nicholas Kristof. Pattani’s articles, on topics ranging from politics to crime to business, have appeared in The Boston Globe, The Texas Tribune, CNBC and The Hartford Courant. Originally from Connecticut, she graduated from Northeastern University in Boston in 2017.
We want your help investigating the business of addiction treatment in Pennsylvania.
More than 200 residential facilities and 600 outpatient providers are licensed by the state, a number that has grown by about one third in the past five years, according to the Department of Drug and Alcohol Programs. Pennsylvania is also home to more than 3,700 medical providers who are allowed to prescribe buprenorphine, a type of medication-assisted treatment, on an outpatient basis.
These facilities and providers are subject to a host of federal and state regulations. But a 2017 report from the auditor general found the Pennsylvania agencies responsible for overseeing addiction treatment struggle to collect accurate data and monitor the effectiveness of their programs, in some cases due to underfunding and understaffing.
We want to fill in the gaps, and we need your help. Using the form below, please share your stories of the struggle to access addiction treatment, predatory providers, inadequate or negligent care and a lack of oversight causing harm to vulnerable residents. We’d also like to hear the success stories and models for efficient and effective treatment.
As the lead reporter on this effort, I assure you we take your privacy seriously and will treat your information with the sensitivity it deserves. We will not share your information with any third-parties or publish details of your story without your permission. If you have additional evidence — including documentation, emails or other people affected — we’re eager to review it all. For questions, please email me at email@example.com.